DVC gets $35.1M tularemia contract

NIH's National Institute of Allergy and Infectious Diseases (NIAID) awarded DVC (Frederick, Md.) a five-year $35.1 million contract to develop next-generation tularemia vaccine candidates. NIAID is ru...